Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HIPP-CABG helium conditioning in CABG surgery
2008-000992-12Phase 2Completed
- Sponsor
- Academic Medical Center
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of heliox in coronary arteriosclerosis, sponsored by Academic Medical Center. Primary endpoint: Myocardial signalling pathway activation (PKC-ε, p38 MAPK, ERK, HSP27). Started Mar 2008; status: completed.
02
Drugs
heliox
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2008-000992-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000992-12.